Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Joseph Saseen to Middle Aged

This is a "connection" page, showing publications Joseph Saseen has written about Middle Aged.

 
Connection Strength
  
 
 
0.732
  
  1. Worledge EA, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. 2025 Jul-Aug; 19(4):860-868.
    View in: PubMed
    Score: 0.051
  2. Fstkchian AK, Lowe RN, Saseen JJ. Statin therapy prescribing in atherosclerotic cardiovascular disease patients with chronic kidney disease. J Am Pharm Assoc (2003). 2025 Jul-Aug; 65(4):102395.
    View in: PubMed
    Score: 0.051
  3. Cheng V, Billups SJ, Saseen JJ. Prescribing practices of migraine-specific pharmacotherapy associated with emergency department use for migraine. Headache. 2021 Mar; 61(3):455-461.
    View in: PubMed
    Score: 0.038
  4. Tunoa JA, Billups SJ, Lowe RN, Saseen JJ. Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation. J Clin Lipidol. 2020 Nov - Dec; 14(6):784-790.
    View in: PubMed
    Score: 0.037
  5. Huntsberry AM, Linnebur SA, Fixen DR, Saba LM, Saseen JJ. Effects of Chronic Proton-Pump Inhibitor Use on Kidney Function in Older Adults. Sr Care Pharm. 2019 May 01; 34(5):325-333.
    View in: PubMed
    Score: 0.034
  6. Wettergreen SA, Brunner J, Linnebur SA, Borgelt LM, Saseen JJ. Comparison of faculty assessment and students' self-assessment of performance during clinical case discussions in a pharmacotherapy capstone course. Med Teach. 2018 02; 40(2):193-198.
    View in: PubMed
    Score: 0.030
  7. Uzal NE, Chavez B, Kosirog ER, Billups SJ, Saseen JJ. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers. Ann Pharmacother. 2018 02; 52(2):160-165.
    View in: PubMed
    Score: 0.030
  8. Vande Griend J, Fixen DR, Fixen CW, Zupec J, Saseen JJ. Clinic-Level Population Health Intervention by PGY2 Ambulatory Care Pharmacy Residents to Optimize Medication Management in a Self-Insured Employer Health Plan Population. J Pharm Pract. 2018 Feb; 31(1):52-57.
    View in: PubMed
    Score: 0.029
  9. McQueen RB, Farahbakhshian S, Bell KF, Nair KV, Saseen JJ. Economic burden of comorbid chronic kidney disease and diabetes. J Med Econ. 2017 Jun; 20(6):585-591.
    View in: PubMed
    Score: 0.029
  10. Anderson HD, Saseen JJ. The importance of clinical research skills according to PharmD students, first-year residents, and residency directors. Curr Pharm Teach Learn. 2017 Mar - Apr; 9(2):224-229.
    View in: PubMed
    Score: 0.029
  11. Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21.
    View in: PubMed
    Score: 0.026
  12. Tuchscherer RM, Nair K, Ghushchyan V, Saseen JJ. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Am J Cardiovasc Drugs. 2015 Feb; 15(1):27-34.
    View in: PubMed
    Score: 0.025
  13. Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. J Clin Hypertens (Greenwich). 2015 Feb; 17(2):134-40.
    View in: PubMed
    Score: 0.025
  14. Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):864-8.
    View in: PubMed
    Score: 0.025
  15. Saseen JJ, Ghushchyan V, Kaila S, Allen RR, Nair KV. Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers. J Clin Hypertens (Greenwich). 2013 Dec; 15(12):888-92.
    View in: PubMed
    Score: 0.023
  16. Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford). 2012 Nov; 51(11):2004-12.
    View in: PubMed
    Score: 0.021
  17. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.
    View in: PubMed
    Score: 0.021
  18. Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.
    View in: PubMed
    Score: 0.016
  19. Sontheimer D, Hitchcock K, Saseen J. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension? J Fam Pract. 2007 Apr; 56(4):312-4.
    View in: PubMed
    Score: 0.015
  20. Claus LW, Auten ME, Saseen JJ, Billups SJ. Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. J Manag Care Spec Pharm. 2025 Sep; 31(9):922-927.
    View in: PubMed
    Score: 0.013
  21. Ho PM, Glorioso TJ, Allen LA, Blankenhorn R, Glasgow RE, Grunwald GK, Khanna A, Magid DJ, Marrs JC, Novins-Montague S, Orlando S, Peterson P, Plomondon ME, Sandy LM, Saseen JJ, Trinkley KE, Vaughn S, Waughtal J, Bull S. Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: A Randomized Pragmatic Trial. JAMA. 2025 01 07; 333(1):49-59.
    View in: PubMed
    Score: 0.013
  22. Hess CN, Daffron A, Nehler MR, Morrison JT, Buchanan CE, Szarek M, Anderson VE, Cannon CP, Hsia J, Saseen JJ, Bonaca MP. Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2024 Jun 25; 83(25):2658-2670.
    View in: PubMed
    Score: 0.012
  23. Potthast KL, Billups SJ, Fixen DR, Titus O, Saseen JJ, Linnebur SA. Evaluation of Aspirin Prescribing and Gastrointestinal Bleeding in Adults 60 Years of Age and Older in a Large, Academic Health System. Sr Care Pharm. 2024 Jun 01; 39(6):218-227.
    View in: PubMed
    Score: 0.012
  24. Bestul MB, McCollum M, Hansen LB, Saseen JJ. Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy. 2004 Apr; 24(4):495-9.
    View in: PubMed
    Score: 0.012
  25. Marrs JC, Orlando ST, Saseen JJ, Novins-Montague S, Sandy LC, Waughtal J, Glorioso TJ, Ho PM. Description of patient questions received by clinical pharmacists in the Nudge Study. Am J Health Syst Pharm. 2023 09 07; 80(18):1247-1254.
    View in: PubMed
    Score: 0.011
  26. Saseen JJ, Hansen LB. What pharmacists need to know about the women's health initiative estrogen plus progestin trial. Am J Health Syst Pharm. 2003 Feb 01; 60(3):281-4.
    View in: PubMed
    Score: 0.011
  27. Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020 04; 75(4):973-981.
    View in: PubMed
    Score: 0.009
  28. Billups SJ, Saseen JJ, Vande Griend JP, Schilling LM. Blood pressure control rates measured in specialty vs primary care practices within a large integrated health system. J Clin Hypertens (Greenwich). 2018 09; 20(9):1253-1259.
    View in: PubMed
    Score: 0.008
  29. Saseen JJ, Porter JA, Barnette DJ, Bauman JL, Zajac EJ, Carter BL. Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients. J Clin Pharmacol. 1997 Jun; 37(6):526-34.
    View in: PubMed
    Score: 0.007
  30. Kelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71.
    View in: PubMed
    Score: 0.007
  31. Graham JH, Sanchez RJ, Saseen JJ, Mallya UG, Panaccio MP, Evans MA. Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system. J Clin Lipidol. 2017 Jan - Feb; 11(1):70-79.e1.
    View in: PubMed
    Score: 0.007
  32. Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension. 1996 Jul; 28(1):109-14.
    View in: PubMed
    Score: 0.007
  33. Fixen CW, Saseen JJ, Vande Griend JP, Linnebur SA. Assessment of blood pressure in patients with hypertension aged 60-79 years before and after the publication of the 2014 Eighth Joint National Committee report. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):67-73.
    View in: PubMed
    Score: 0.007
  34. Vande Griend JP, Saseen JJ, Bislip D, Emsermann C, Conry C, Pace WD. Prioritization of patients for comprehensive medication review by a clinical pharmacist in family medicine. J Am Board Fam Med. 2015 May-Jun; 28(3):418-24.
    View in: PubMed
    Score: 0.006
  35. Thompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KV. Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors. J Oncol Pharm Pract. 2015 Aug; 21(4):258-67.
    View in: PubMed
    Score: 0.006
  36. Alford JC, Saseen JJ, Allen RR, Nair KV. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy. 2012 Jul; 32(7):623-30.
    View in: PubMed
    Score: 0.005
  37. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.
    View in: PubMed
    Score: 0.005
  38. Nair KV, Miller K, Park J, Allen RR, Saseen JJ, Biddle V. Prescription co-pay reduction program for diabetic employees. Popul Health Manag. 2010 Oct; 13(5):235-45.
    View in: PubMed
    Score: 0.005
  39. Nair KV, Park J, Wolfe P, Saseen JJ, Allen RR, Ganguly R. Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers. J Occup Environ Med. 2009 May; 51(5):594-603.
    View in: PubMed
    Score: 0.004
  40. Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther. 2003 Nov; 25(11):2936-57.
    View in: PubMed
    Score: 0.003
  41. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000 Nov; 20(11):1384-9.
    View in: PubMed
    Score: 0.002
  42. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy. 2000 Oct; 20(10):1159-66.
    View in: PubMed
    Score: 0.002
  43. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med. 2000 Aug; 9(8):722-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)